ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 212446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 212446; 2) Community: the network communities that were significantly associated with the response to NSC 212446; 3) Molecule: the relationships between components within communities and NSC 212446; 4) MDR: the compounds that were significantly associated with the NSC 212446.

NSC Compound Enrichment Correlation
NSC 109084 Null 0.0038671642008129 0.30091128
NSC 138780 8-(3-Methylbutyryloxy)diacetoxyscirpenol 0.0038671642008129 0.47629857
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0038671642008129 0.41939956
NSC 624172 Null 0.0038671642008129 0.20760128
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.0038671642008129 0.37946985
NSC 645317 Sanguilutine pseudobase 0.0038671642008129 0.39979419
NSC 671316 Null 0.0038671642008129 0.59727531
NSC 690116 Null 0.0038671642008129 0.55111284
NSC 701748 Null 0.0038671642008129 0.5309712
NSC 724780 (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 0.0038671642008129 0.45616273
Total:135  Current:25    [First] [Prev] [Next] [Last]